Research location
Bruges
West-Vlaanderen, Belgium
Advertisement
Research activity in Bruges
West-Vlaanderen, BelgiumCureCurrent currently publishes aggregate city-level research activity for this location: 22 trials and 22 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bruges
22 linked trials · page 1 of 1A Study Comparing an Investigational Wound Gel With Standard Treatment for Mild to Moderate Diabetic Foot UlcersNCT07783087 · 2026-08-10 · 1 site observation
RECRUITING
A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in BelgiumNCT07382440 · 2026-03-09 · 1 site observation
RECRUITING
Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric SurgeryNCT06881485 · 2025-01-20 · 1 site observation
RECRUITING
Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung CancerNCT06057766 · 2024-01-01 · 1 site observation
RECRUITING
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 DiabetesNCT05777330 · 2023-08-09 · 1 site observation
RECRUITING
Prospective Prostate Cancer and Patient-reported Outcomes RegistryNCT04694924 · 2020-10-01 · 1 site observation
RECRUITING
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT05814627 · 2023-06-15 · 1 site observation
COMPLETED
Prevalence of Glaucoma in Belgium: a Multicenter National TrialNCT05703724 · 2023-03-08 · 1 site observation
COMPLETED
App-based Education and GOal-setting in Rheumatoid ArthritisNCT05888181 · 2023-03-03 · 1 site observation
COMPLETED
Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization TherapyNCT05365568 · 2022-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseNCT04379050 · 2020-06-08 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29 · 1 site observation
COMPLETED
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT03778931 · 2019-05-10 · 1 site observation
COMPLETED
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RANCT03649061 · 2018-06-08 · 1 site observation
COMPLETED
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid TumorsNCT03511391 · 2018-03-09 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03NCT03420781 · 2018-01-24 · 1 site observation
TERMINATED
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerNCT02492711 · 2015-08-24 · 1 site observation
COMPLETED
Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).NCT02525874 · 2015-08-11 · 1 site observation
COMPLETED
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerNCT02163694 · 2014-04-08 · 1 site observation
COMPLETED
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerNCT01506609 · 2012-01-23 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.